Baudax Bio, Inc. Quarterly Cost of Revenue in USD from Q2 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Baudax Bio, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q4 2022.
  • Baudax Bio, Inc. Cost of Revenue for the quarter ending December 31, 2022 was $4.79M, a 732% increase year-over-year.
  • Baudax Bio, Inc. Cost of Revenue for the twelve months ending December 31, 2022 was $7.01M, a 187% increase year-over-year.
  • Baudax Bio, Inc. annual Cost of Revenue for 2022 was $7.01M, a 187% increase from 2021.
  • Baudax Bio, Inc. annual Cost of Revenue for 2021 was $2.45M, a 41.2% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $7.01M $4.79M +$4.22M +732% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 $2.79M $1.21M +$746K +161% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.05M $361K -$225K -38.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.27M $648K -$173K -21.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.45M $576K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $462K -$78K -14.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $586K -$64K -9.85% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $821K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $540K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $650K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.